Leukemia, Myeloid, Acute

"Leukemia, Myeloid, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Descriptor ID	D015470
MeSH Number(s)	C04.557.337.539.275
Concept/Terms	Leukemia, Myeloid, Acute Leukemia, Myeloid, Acute Acute Myeloid Leukemia Acute Myeloid Leukemias Leukemias, Acute Myeloid Myeloid Leukemias, Acute ANLL Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Myeloblastic, Acute Leukemia, Myelocytic, Acute Leukemia, Myelogenous, Acute Leukemia, Nonlymphoblastic, Acute Leukemia, Nonlymphocytic, Acute Myeloblastic Leukemia, Acute Acute Myeloblastic Leukemia Acute Myeloblastic Leukemias Leukemia, Acute Myeloblastic Leukemias, Acute Myeloblastic Myeloblastic Leukemias, Acute Myelocytic Leukemia, Acute Acute Myelocytic Leukemia Acute Myelocytic Leukemias Leukemia, Acute Myelocytic Leukemias, Acute Myelocytic Myelocytic Leukemias, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Nonlymphoblastic Leukemia, Acute Acute Nonlymphoblastic Leukemia Acute Nonlymphoblastic Leukemias Leukemia, Acute Nonlymphoblastic Leukemias, Acute Nonlymphoblastic Nonlymphoblastic Leukemias, Acute Nonlymphocytic Leukemia, Acute Acute Nonlymphocytic Leukemia Acute Nonlymphocytic Leukemias Leukemia, Acute Nonlymphocytic Leukemias, Acute Nonlymphocytic Nonlymphocytic Leukemias, Acute Acute Myelogenous Leukemia Acute Myelogenous Leukemias Leukemias, Acute Myelogenous Myelogenous Leukemias, Acute Myeloid Leukemia, Acute, M1 Myeloid Leukemia, Acute, M1 Leukemia, Myeloid, Acute, M1 Acute Myeloid Leukemia without Maturation Leukemia, Myeloid, Acute, M2 Leukemia, Myeloid, Acute, M2 Myeloid Leukemia, Acute, M2 Acute Myeloid Leukemia with Maturation

Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Acute".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Leukemia [C04.557.337]
Leukemia, Myeloid [C04.557.337.539]
Leukemia, Myeloid, Acute [C04.557.337.539.275]

Below are MeSH descriptors whose meaning is related to "Leukemia, Myeloid, Acute".

Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Acute".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leukemia, Myeloid, Acute" by people in this website by year, and whether "Leukemia, Myeloid, Acute" was a major or minor topic of these publications.

Bar chart showing 23 publications over 13 distinct years, with a maximum of 4 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2002	1	1
2004	1	1
2010	2	2
2011	1	1
2012	2	2
2013	2	2
2014	1	1
2015	1	1
2017	2	2
2018	2	2
2020	3	3
2021	1	1
2022	4	4

Below are the most recent publications written about "Leukemia, Myeloid, Acute" by people in Profiles.

A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leuk Lymphoma. 2023 02; 64(2):473-477.

View in: PubMed
Transplant outcomes after CPX-351 vs 7?+?3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022 09 13; 6(17):4989-4993.

View in: PubMed
Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database. Curr Probl Cardiol. 2022 11; 47(11):101345.

View in: PubMed
Code status transitions in patients with high-risk acute myeloid leukemia. Blood Adv. 2022 07 26; 6(14):4208-4215.

View in: PubMed
HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression. Blood. 2022 05 05; 139(18):2797-2815.

View in: PubMed
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia. Am J Hematol. 2022 06 01; 97(6):E191-E194.

View in: PubMed
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol. 2021 Jul; 8(7):e481-e491.

View in: PubMed
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. J Clin Oncol. 2021 10 10; 39(29):3261-3272.

View in: PubMed
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses. Blood Adv. 2021 03 23; 5(6):1719-1728.

View in: PubMed
Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression. Microb Cell Fact. 2021 Mar 10; 20(1):67.

View in: PubMed

People

Explore

Similar Concepts

Top Journals